Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With most brokers taking a break over the holiday period, research notes are few and far between right now.

But don't worry! Listed below are three recent broker buy recommendations that still have plenty of upside potential.

Here's why brokers think these ASX shares are in the buy zone:

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.

Image source: Getty Images

Pilbara Minerals Ltd (ASX: PLS)

According to a note from Bell Potter, its analysts upgraded this lithium miner's shares to a buy rating with a $2.95 price target.

The broker made the move for a couple of key reasons. The first was on valuation grounds believing that a sharp pullback in its share price has created a buying opportunity for investors. Especially now that short interest in the lithium miner is falling.

Another key reason to invest, according to Bell Potter, is the improving outlook for lithium. Its analysts believe that there could be lithium supply deficits from 2026, which would be a huge boost to prices.

And with Pilbara Minerals having a very strong balance sheet, Bell Potter feels that it is well-placed to respond. The Pilbara Minerals share price is trading at $2.24 this morning.

Pro Medicus Limited (ASX: PME)

A note from Goldman Sachs revealed that its analysts retained their buy rating on this health imaging technology company's shares with an improved price target of $278.00.

The broker believes that Pro Medicus is one of Australia's best global growth companies. This is based partly on its belief that further Visage 7 adoption is a matter of when not if. Goldman is forecasting a strong increase in the value and cadence of contract wins over time.

And while it acknowledges that Pro Medicus' shares are not cheap, trading on 114x FY26E EV/EBITDA, the broker feels that this premium is justified due to its revenue/margin outlook, unique cloud offering, and significant long-term opportunity. The Pro Medicus share price is fetching $250.14 on Friday.

Super Retail Group Ltd (ASX: SUL)

Analysts at Morgans retained their add rating on this retail group's shares with a trimmed price target of $18.55. This followed the release of a first-quarter update from the BCF, Rebel, Macpac, and Supercheap Auto owner.

Morgans notes that the update was a touch softer than expected. This has led to its analysts trimming their earnings forecasts to reflect the challenging trading conditions in the auto parts industry.

Nevertheless, the broker remains positive on its outlook and sees plenty of value on offer with its shares. In addition, Morgans expects Super Retail's shares to offer 6%+ fully franked dividend yields in the near term. The Super Retail share price is trading at $15.34 today.

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Super Retail Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Super Retail Group. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Buy, hold, sell: Collins Foods, Netwealth, and Pro Medicus shares

How does the broker rate these popular shares this month?

Read more »

A smiling florist gets some good news on his laptop and tablet.
Broker Notes

What is Morgan's view on Navigator Global Investments shares after update

Morgans sees further upside for this stock.

Read more »

Cheerful businessman with a mining hat on the table sitting back with his arms behind his head while looking at his laptop's screen.
Broker Notes

What are brokers predicting for BHP shares over the next 12 months?

Have the mining giant's shares reached their peak? Or can they keep climbing? Let's find out.

Read more »

A young woman wearing a red and white striped t-shirt puts her hand to her chin and looks sideways as she wonders whether to buy ASX shares
Broker Notes

Buy, hold, sell: Aristocrat, Lovisa, Bendigo Bank shares

Here's what some experts think.

Read more »

A businesswoman on the phone is shocked as she looks at her watch, she's running out of time.
Broker Notes

Is this ASX 200 share a sell after announcing a $30-40 million EBITA hit?

Morgans has lowered its outlook on Worley shares.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Broker Notes

Should you buy BHP shares ahead of the miner's production update?

BHP shares could see some big moves after the miner reports its March production results this week.

Read more »

A woman looks questioning as she puts a coin into a piggy bank.
Broker Notes

Buy, hold, or sell? Coles, Wesfarmers, BHP shares

ASX 200 shares are in the red as the global oil shock continues to concern investors.

Read more »

Health professional working on his laptop.
Broker Notes

Are Orthocell shares a buy after crashing 7% yesterday?

These healthcare shares could be on discount right now.

Read more »